XML 70 R57.htm IDEA: XBRL DOCUMENT v3.25.0.1
Summary of Significant Accounting Policies - Summary of Calculation of Basic and Diluted EPS (Parenthetical) (Details) - shares
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Weighted-average common and potential dilutive common shares outstanding, diluted [1] 30,962,000 31,303,000 30,046,000
Performance Stock Units (“PSUs”) and Nonvested Restricted Stock Awards      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Weighted-average common and potential dilutive common shares outstanding, diluted 31,092,693 31,330,597 30,206,521
Antidilutive securities excluded from the computation of EPS (shares) 130,527 27,434 160,098
[1] . For the year ended December 31, 2023, the computation of diluted EPS does not include contingently issuable shares due to their anti-dilutive nature. Had the contingently issuable shares been dilutive, the denominator for diluted EPS would have been 31,330,597, including 27,434 contingently issuable shares related to unvested restricted stock awards. Due to a net loss for the year ended December 31, 2022, the computation of diluted EPS does not include contingently issuable shares due to their anti-dilutive nature. Had the Company reported net income for the year ended December 31, 2022, the denominator for diluted EPS would have been 30,206,521, including 160,098 contingently issuable shares related to PSUs and unvested restricted stock awards.